Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$5.36
-0.9%
$5.25
$4.22
$8.90
$61.39M0.248,086 shs5,882 shs
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$0.57
+1.8%
$0.65
$0.52
$1.35
$43.66M0.9783,097 shs221,958 shs
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$0.94
$0.56
$1.30
$63.04M2.3541,468 shs303,600 shs
Sientra, Inc. stock logo
SIEN
Sientra
$0.43
$0.16
$4.94
$2.08M2.044.15 million shs3.44 million shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-0.92%+2.29%+2.29%+7.20%-23.43%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
+1.97%-0.25%-9.09%-5.60%-25.01%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.00%0.00%0.00%+6.07%+67.21%
Sientra, Inc. stock logo
SIEN
Sientra
0.00%0.00%0.00%-71.01%-87.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
2.3736 of 5 stars
3.55.00.00.01.90.00.6
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
3.00
Buy$11.00105.22% Upside
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.00
Buy$3.00∞ Upside
Sientra, Inc. stock logo
SIEN
Sientra
2.00
HoldN/AN/A

Current Analyst Ratings

Latest SIEN, MLSS, RWLK, and CLGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/5/2024
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$11.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
$10.96M5.60N/AN/A$2.47 per share2.17
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
$9.83M4.44N/AN/A$0.11 per share5.18
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$5.51M0.00N/AN/A$1.10 per share0.00
Sientra, Inc. stock logo
SIEN
Sientra
$90.55M0.00N/AN/A($0.04) per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
-$7.02M-$0.64N/AN/AN/A-64.05%-22.17%-18.84%5/22/2024 (Estimated)
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
-$6.93M-$0.10N/AN/A-70.50%-86.72%-61.08%N/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
-$19.57M-$0.37N/AN/AN/A-238.35%-29.00%-25.27%N/A
Sientra, Inc. stock logo
SIEN
Sientra
-$73.31M-$5.57N/AN/AN/A-65.93%N/A-40.45%N/A

Latest SIEN, MLSS, RWLK, and CLGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/4/2024Q4 2023
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A-$0.42-$0.42-$0.42N/A$0.30 million
3/29/2024Q4 2023
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A-$0.03-$0.03-$0.03N/A$2.26 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/AN/AN/AN/AN/A
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/A
Sientra, Inc. stock logo
SIEN
Sientra
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
N/A
8.62
8.40
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
N/A
3.51
2.65
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/A
3.47
2.99
Sientra, Inc. stock logo
SIEN
Sientra
N/A
0.57
0.31

Ownership

Institutional Ownership

CompanyInstitutional Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
21.69%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
5.79%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.58%
Sientra, Inc. stock logo
SIEN
Sientra
15.38%

Insider Ownership

CompanyInsider Ownership
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
9.60%
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
25.20%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
2.10%
Sientra, Inc. stock logo
SIEN
Sientra
1.53%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
CollPlant Biotechnologies Ltd. stock logo
CLGN
CollPlant Biotechnologies
7311.45 million10.35 millionOptionable
Milestone Scientific Inc. stock logo
MLSS
Milestone Scientific
1776.60 million57.30 millionOptionable
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
5660.03 million58.76 millionOptionable
Sientra, Inc. stock logo
SIEN
Sientra
30411.96 million11.78 millionOptionable

SIEN, MLSS, RWLK, and CLGN Headlines

SourceHeadline
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
bignewsnetwork.com - April 24 at 6:29 PM
California-based manufacturer of breast implants closing Franklin facility as part of bankruptcyCalifornia-based manufacturer of breast implants closing Franklin facility as part of bankruptcy
biztimes.com - April 22 at 2:14 PM
Sientra Inc SIENQSientra Inc SIENQ
morningstar.com - April 22 at 12:31 AM
Nuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis PortfolioNuance Medical Completes Acquisition of BIOCORNEUM Scar Treatment Brand, to Become a Part of the Biodermis Portfolio
finance.yahoo.com - April 18 at 3:40 PM
Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033Aesthetic Implants Market: In-Depth Analysis, Emerging Trends, Growth Drivers, and Forecasts up to 2033
pharmiweb.com - April 13 at 7:57 AM
Breast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.bizBreast Implants Market to Reach USD 7.8 Billion by 2032, CAGR 6.7% | Marketresearch.biz
pharmiweb.com - April 12 at 5:47 AM
Nasdaq (NDAQ) Initiated with a Buy at BarclaysNasdaq (NDAQ) Initiated with a Buy at Barclays
markets.businessinsider.com - April 11 at 7:34 AM
Medical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth RateMedical Aesthetics Market Future Projections: USD 51.7 Billion By 2032 With A Consistent 14.7% Growth Rate
pharmiweb.com - April 8 at 4:33 PM
Global Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI AnalysisGlobal Extremity Tissue Expanders Industry Expected to Grow at a Startling 6.3% CAGR to Reach US$ 1,842.6 Million by 2028 | FMI Analysis
fmiblog.com - April 4 at 6:23 PM
Aesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.usAesthetic Implants Market on Track for Remarkable Expansion, Forecasted to Surpass USD 10 Billion by 2032 | Market.us
pharmiweb.com - April 4 at 8:22 AM
Sientra Sells Business Parts for $50M+Sientra Sells Business Parts for $50M+
ocbj.com - April 3 at 3:53 PM
Sientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra, Inc.: Sientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
finanznachrichten.de - April 3 at 10:53 AM
Nuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment BrandNuance Medical Agrees to Acquire BIOCORNEUM Scar Treatment Brand
finance.yahoo.com - April 3 at 10:53 AM
Sientra Announces Completion and Winning Bidders of its Section 363 Sales AuctionSientra Announces Completion and Winning Bidders of its Section 363 Sales Auction
globenewswire.com - April 2 at 6:30 PM
Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%Global Gynecomastia Procedures Market Size To Exceed USD 1900 Million by 2033 | CAGR Of 8.05%
finance.yahoo.com - March 15 at 4:23 AM
Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032Global Cosmetic Implants Market, with a special focus on dental implants, is anticipated to hit a remarkable US$ 17.9 Billion by 2032
fmiblog.com - March 14 at 11:23 PM
Firm Retention Summary: SientraFirm Retention Summary: Sientra
wsj.com - March 7 at 3:39 PM
Sientra Declares Bankruptcy, Seeks BuyerSientra Declares Bankruptcy, Seeks Buyer
ocbj.com - February 26 at 7:00 PM
Global Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMIGlobal Extremity Tissue Expanders Industry Poised for a Meteoric Rise, Anticipating US$ 1,842.6 Million with a Resounding 6.3% CAGR by 2028 | FMI
fmiblog.com - February 21 at 3:22 PM
SIEN Mar 2024 2.500 callSIEN Mar 2024 2.500 call
finance.yahoo.com - February 17 at 8:46 AM
Sientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 ProcessSientra, Inc.: Sientra to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process
finanznachrichten.de - February 15 at 3:24 PM
Plastic surgery company goes bust, files Chapter 11 bankruptcyPlastic surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 3:24 PM
Plastic-surgery company goes bust, files Chapter 11 bankruptcyPlastic-surgery company goes bust, files Chapter 11 bankruptcy
msn.com - February 15 at 10:23 AM
Implant Maker Sientra Cleared to Draw Deerfield Bankruptcy LoanImplant Maker Sientra Cleared to Draw Deerfield Bankruptcy Loan
msn.com - February 14 at 6:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

CollPlant Biotechnologies logo

CollPlant Biotechnologies

NASDAQ:CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; injectable implants to promote breast tissue regeneration; 3D bioprinted regenerative soft tissue matrix; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds. It has collaboration agreements with 3D Systems Corporation; CellInk, a BICO Group company; Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; Israel's Technion Institute of Technology; Tel Aviv University; Sheba Medical Center; AbbVie; and STEMCELL. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.
Milestone Scientific logo

Milestone Scientific

NYSE:MLSS
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
ReWalk Robotics logo

ReWalk Robotics

NASDAQ:RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.
Sientra logo

Sientra

NASDAQ:SIEN
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.